Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 2Lymphoma, T-Cell, Cutaneous 2Lichen Planus, Oral 2Stomach Neoplasms 1Retinal Diseases 1Recurrence 1Radiodermatitis 1Pain 1Neuroma, Acoustic 1Mycosis Fungoides 1Melanoma 1Macular Degeneration 1Lymphomatoid Papulosis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leiomyoma 1Glioblastoma 1Fibroma 1Exanthema 1Esophageal Stenosis Acquired 1Dupuytren Contracture 1Disease 1Dermatitis, Contact 1Choroid Diseases 1Chalazion 1Castration Resistant Prostate Cancer 1Breast Neoplasms 1Adenomyosis 1

Interventions

Imatinib Mesylate 2telapristone acetate 1seclidemstat 1Uterine Myomectomy 1Triamcinolone Acetonide 1Topotecan 1Specimen Handling 1Sodium Chloride 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hydroxyurea 1Cyclophosphamide 1CTLA-4 Antigen 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fibroma × Triamcinolone Acetonide × Clear all
NCT03627741 2022-08-25

A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors

Mayo Clinic

Phase 1 Completed
10 enrolled

Fibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡